Skip to main content
VCbacked
Log inGet Started

Garuda Therapeutics

Cambridge, United States

Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.

$50.0M raised
Mar 2025
Series A
BiotechnologyHealth CareLife ScienceTherapeutics

Top Investors

OrbiMedCormorant Asset ManagementResilienceAisling CapitalAlexandria Venture Investments

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Garuda Therapeutics

How much funding has Garuda Therapeutics raised?
Garuda Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in March 2025.
Who are Garuda Therapeutics's investors?
Garuda Therapeutics's investors include OrbiMed, Cormorant Asset Management, Resilience, Aisling Capital, Alexandria Venture Investments.
Where is Garuda Therapeutics headquartered?
Garuda Therapeutics is headquartered in Cambridge, United States.
What does Garuda Therapeutics do?
Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat severe and life-threatening diseases.
What stage is Garuda Therapeutics at?
Garuda Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Garuda Therapeutics — Funding & Investors." VCBacked, March 4, 2025, https://www.vcbacked.co/company/garuda-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Garuda Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/garuda-therapeutics
Wikipedia (cite web)
{{cite web |title=Garuda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/garuda-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong